Linked Life Data

19903091

Source:http://linkedlifedata.com/resource/pubmed/id/19903091

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2009-12-8
pubmed:abstractText
The use of bisphosphonates (zoledronic acid) in the treatment of metastatic bone disease has been raised during recent years. The purpose of this treatment is mainly to reduce skeletal-related events, e.g. pain and pathological fractures. The aim of this study was to report the incidence of bisphosphonate-related osteonecrosis of the jaw (ONJ).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1651-2065
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
43
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
442-4
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Bisphosphonate (zoledronic acid)-induced osteonecrosis of the jaw.
pubmed:affiliation
Department of Urology, Viborg County Hospital, Viborg, Denmark.
pubmed:publicationType
Journal Article